dnaJ Peptide for Relieving Rheumatoid Arthritis

NCT00000435 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

NIH

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: dnaJ peptide
DRUG: None-placebo

Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)